Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders
- PMID: 11589918
- DOI: 10.1016/s0047-6374(01)00304-9
Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders
Abstract
The reliability of cerebrospinal fluid (CSF)-tau and CSF-beta-amyloid assays for diagnosis of Alzheimer's disease and other dementing disorders such as frontotemporal dementia (FTD), dementia with Lewy bodies (DLB) and Creutzfeldt-Jakob disease (CJD) is reviewed. CSF assessment of the two proteins is useful in early diagnosis of AD and to differentiate it from FTD and DLB. Extremely high CSF-tau levels can discriminate CJD from AD.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
